EIGR
Eiger BioPharmaceuticals, Inc.
Set alert
52-week range unavailable
- Open
- 1.90
- Prev close
- 1.73
- Mkt cap
- 2.55M
- Vol
- 136.27K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.73
- High
- 1.90
- Forward P/E
- -0.48
- Beta
- 1.84
- Short ratio
- 3.72
- Inst. own
- 43.86%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 9, 2024
- 50-d avg
- 4.59
- 200-d avg
- 10.27
- 1y target
- 30.00
News
2 years ago marketwatch.com
Healthcare stocks fade as obesity-drug optimism fades
Healthcare companies fell sharply Monday as ebullience about a new class of weight control drugs subsided.
-
2 years ago benzinga.com
Why Nuvve Holding Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Nuvve Holding Corp. (NASDAQ: NVVE) fell sharply during Monday’s session after the company reported worse-than-expected fourth-quarter financial results.
-
2 years ago benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's Intraday Session
2 years ago globenewswire.com
Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection
Announces “Stalking Horse” Agreement for the Sale of Zokinvy ® (lonafarnib) Patient Access to Zokinvy ® to Continue Uninterrupted PALO ALTO, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Eiger…
-
2 years ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
2 years ago prnewswire.com
Eiger and Partner, AnGes, Receive Approval for Zokinvy® (lonafarnib) for Hutchinson- Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies in Japan
Clinical trial data demonstrated Zokinvy treatment extended life by an average of 4.3 years in children and young adults with Hutchinson-Gilford progeria Eiger to receive $500,000 approval milestone…
2 years ago prnewswire.com
Eiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse Stock Split
PALO ALTO, Calif. , Jan. 4, 2024 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR) (the "Company"), a commercial-stage biopharmaceutical company focused on the development of innovative…
-
3 years ago benzinga.com
Why Clearmind Medicine Shares Are Trading Lower By 53%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares jumped 89.5% to $0.8243 after the company announced license agreement for capeserod from Sanofi.
-
3 years ago benzinga.com
Why Novo Integrated Sciences Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares rose 43.3% to $1.29 in pre-market trading.
-
3 years ago benzinga.com
Why Eiger BioPharmaceuticals Shares Are Trading Lower By 52%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares surged 68% to $0.2075. Avalo Therapeutics, on Sept 12, got notice from the Nasdaq as of Sept 11 the company’s securities had closing bid price…
3 years ago investorplace.com
Why Is Eiger BioPharmaceuticals (EIGR) Stock Down 31% Today?
Eiger BioPharmaceuticals (NASDAQ: EIGR ) stock is falling on Wednesday after the biopharmaceutical company halted a Phase 3 clinical trial. According to a press release from the company, it has…
3 years ago prnewswire.com
Eiger to Discontinue Phase 3 LIMT-2 Trial of Peginterferon Lambda in Patients with Chronic Hepatitis Delta
PALO ALTO, Calif., Sept. 12, 2023 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies for…
3 years ago prnewswire.com
Eiger BioPharmaceuticals to Present at H.C. Wainwright 25th Annual Global Investment Conference
PALO ALTO, Calif. , Sept. 5, 2023 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies for…
3 years ago prnewswire.com
Eiger BioPharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update
Resources prioritized to advance avexitide in hyperinsulinemic hypoglycemia indications Active discussions underway with potential partners to advance late-stage virology programs Reduction in…
-
3 years ago benzinga.com
Why Cineverse Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Addentax Group Corp. (NASDAQ: ATXG) shares jumped 47.3% to $9.68. Addentax Group is launching automation of artificial intelligence internet operational tools project with top…
3 years ago seekingalpha.com
Eiger BioPharmaceuticals: Wall Street Has High Expectations For Faltering Battleground Stock
Wall Street Analysts have high expectations for Eiger. Eiger has a modest pipeline. Expect near term data to impact the stock in a big way.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
Monday's session saw 114 companies set new 52-week lows.
3 years ago pulse2.com
EIGR Stock: 23.53% Surge Explanation
The stock price of Eiger BioPharmaceuticals Inc. (Nasdaq: EIGR) surged by 23.53% today. This is why.
3 years ago barrons.com
7 Cheap But Risky Biotech Stocks
Biotech stocks remain depressed, nearly two years into a dip that has seen the SPDR S&P Biotech ETF drop nearly 50%.
3 years ago pennystocks.com
Best Penny Stocks To Buy? 4 To Watch Before 2023
Penny stocks to watch before next year. The post Best Penny Stocks To Buy?
3 years ago pennystocks.com
Best Penny Stocks To Buy Now? 4 Stocks Under $4 To Watch
Penny stocks to watch this week. The post Best Penny Stocks To Buy Now?
3 years ago prnewswire.com
Eiger BioPharmaceuticals to Host Conference Call to Discuss Phase 3 D-LIVR Study Results of Lonafarnib-based Treatments in Hepatitis Delta Virus (HDV) on Thursday, December 8, 2022
Live Conference Call and Webcast at 8:30 AM ET PALO ALTO, Calif. , Dec. 7, 2022 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), a commercial-stage biopharmaceutical company focused on…
3 years ago seekingalpha.com
Eiger BioPharmaceuticals: A Compelling High Beta Story
Today, we revisit the investment case around Eiger BioPharmaceuticals for the first time in more than a year and a half. Eiger has one product on the market and is rapidly advancing a powerful 'sum…
3 years ago seekingalpha.com
Eiger BioPharmaceuticals, Inc. (EIGR) Q3 2022 Earnings Call Transcript
Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR ) Q3 2022 Results Conference Call November 3, 2022 4:30 PM ET Company Participants Sarah Mathieson - Senior Vice President, Corporate Affairs David Cory -…
3 years ago zacks.com
Eiger BioPharmaceuticals (EIGR) Reports Q3 Loss, Tops Revenue Estimates
Eiger BioPharma (EIGR) delivered earnings and revenue surprises of -12.73% and 2.39%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
-
3 years ago benzinga.com
Earnings Scheduled For November 3, 2022
Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.
4 years ago marketwatch.com
Eiger's stock falls 20% after telling investors it won't seek FDA authorization for COVID-19 drug
Shares of Eiger BioPharmaceuticals Inc. EIGR, -1.20% tumbled 20.4% in premarket trading on Wednesday after the company said it will not pursue emergency authorization of its experimental treatment…
4 years ago seekingalpha.com
Eiger BioPharmaceuticals, Inc. (EIGR) CEO David Cory on Q2 2022 Results - Earnings Call Transcript
Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Sarah Mathieson - SVP, Corporate Affairs David Cory - President & CEO…
4 years ago zacks.com
Eiger BioPharmaceuticals (EIGR) Reports Q2 Loss, Tops Revenue Estimates
Eiger BioPharma (EIGR) delivered earnings and revenue surprises of 28.17% and 94.81%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
-
4 years ago benzinga.com
Earnings Scheduled For August 4, 2022
Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is projected to report earnings for its first quarter.
-
4 years ago benzinga.com
Earnings Scheduled For May 5, 2022
Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
-
4 years ago benzinga.com
95 Biggest Movers From Friday
Gainers Marygold Companies (NYSE: MGLD) shares surged 89.4% to close at $4.11 on Friday after dropping 21% on Thursday. TeraWulf Inc. (NASDAQ: WULF) gained 49.3% to close at $9.51.
-
4 years ago benzinga.com
Earnings Scheduled For March 10, 2022
Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's morning trading, 400 companies set new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
-
4 years ago benzinga.com
Earnings Scheduled For November 4, 2021
Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
On Friday morning, 155 companies achieved new lows for the year.
-
5 years ago benzinga.com
Earnings Scheduled For August 5, 2021
Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.
-
5 years ago benzinga.com
Earnings Scheduled For May 6, 2021
Companies Reporting Before The Bell • ViacomCBS (NASDAQ:VIAC) is projected to report quarterly earnings at $1.22 per share on revenue of $7.30 billion.
-
5 years ago benzinga.com
60 Stocks Moving In Thursday's Mid-Day Session
Gainers Immutep Limited (NASDAQ: IMMP) shares jumped 198.6% to $6.42 after the company said its Chinese partner,
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Monday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Thursday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
Stocks That Hit 52-Week Lows On Tuesday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Thursday
-
8 years ago benzinga.com
36 Stocks Moving In Wednesday's Mid-Day Session
36 Stocks Moving In Wednesday's Mid-Day Session
-
8 years ago benzinga.com
26 Stocks Moving In Friday's Mid-Day Session
26 Stocks Moving In Friday's Mid-Day Session
-
8 years ago benzinga.com
32 Stocks Moving In Monday's Mid-Day Session
32 Stocks Moving In Monday's Mid-Day Session